These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 24191524)

  • 1. Sugammadex: the good, the bad and the ugly.
    Vercauteren M
    Acta Anaesthesiol Belg; 2013; 64(2):39-40. PubMed ID: 24191524
    [No Abstract]   [Full Text] [Related]  

  • 2. Sugammadex in anesthesia practice.
    Duvaldestin P; Plaud B
    Expert Opin Pharmacother; 2010 Nov; 11(16):2759-71. PubMed ID: 20977408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cochrane corner: sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
    Abrishami A; Ho J; Wong J; Yin L; Chung F
    Anesth Analg; 2010 Apr; 110(4):1239. PubMed ID: 20357160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trial.
    Blobner M; Eriksson LI; Scholz J; Motsch J; Della Rocca G; Prins ME
    Eur J Anaesthesiol; 2010 Oct; 27(10):874-81. PubMed ID: 20683334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: a multicenter, randomized, controlled trial.
    Khuenl-Brady KS; Wattwil M; Vanacker BF; Lora-Tamayo JI; Rietbergen H; Alvarez-Gómez JA
    Anesth Analg; 2010 Jan; 110(1):64-73. PubMed ID: 19713265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomised controlled trial comparing sugammadex and neostigmine at different depths of neuromuscular blockade in patients undergoing laparoscopic surgery.
    Geldner G; Niskanen M; Laurila P; Mizikov V; Hübler M; Beck G; Rietbergen H; Nicolayenko E
    Anaesthesia; 2012 Sep; 67(9):991-8. PubMed ID: 22698066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
    de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M
    Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sugammadex: a new approach to the use of neuromuscular blockers].
    Alvarez-Gómez JA; Veiga-Ruiz G
    Rev Esp Anestesiol Reanim; 2011 Jun; 58 Suppl 2():20-3. PubMed ID: 21916086
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful use of rocuronium and sugammadex in a patient with myasthenia.
    Petrun AM; Mekis D; Kamenik M
    Eur J Anaesthesiol; 2010 Oct; 27(10):917-8. PubMed ID: 20375901
    [No Abstract]   [Full Text] [Related]  

  • 10. [Sugammadex used in a patient with hereditary spastic paraplegia].
    Ortega U; Renedo P; Figueroa G; Aguirre J
    Rev Esp Anestesiol Reanim; 2011 Dec; 58(10):619-20. PubMed ID: 22263409
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of sugammadex in a patient with myotonic dystrophy.
    Matsuki Y; Hirose M; Tabata M; Nobukawa Y; Shigemi K
    Eur J Anaesthesiol; 2011 Feb; 28(2):145-6. PubMed ID: 20962659
    [No Abstract]   [Full Text] [Related]  

  • 12. Reversal of rocuronium-induced neuromuscular block with sugammadex in heart failure patients: a prospective observational study.
    Cammu G; Coart D; De Graeve K; Beelen R
    Acta Anaesthesiol Belg; 2012; 63(2):69-73. PubMed ID: 23136807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rocuronium used in rapid sequence intubation and reversal with sugammadex in a patient with myasthenia gravis].
    Illodo Miramontes G; Doniz Campos M; Filgueira Garrido P; Vázquez Martínez A
    Rev Esp Anestesiol Reanim; 2011 Dec; 58(10):626-7. PubMed ID: 22263415
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of sugammadex for reversal of neuromuscular blockade in 2 patients requiring intraoperative neurophysiological monitoring.
    Reid S; Shields MO; Luney SR
    J Neurosurg Anesthesiol; 2011 Jan; 23(1):56-7. PubMed ID: 21248496
    [No Abstract]   [Full Text] [Related]  

  • 15. Sugammadex: a selective relaxant binding agent for reversal of neuromuscular block.
    Hogg RM; Mirakhur RK
    Expert Rev Neurother; 2009 May; 9(5):599-608. PubMed ID: 19402771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rocuronium-sugammadex complex in the reversal of neuromuscular blockade after implantation of an endobronchial stent following lung transplant].
    Brito Jiménez LG; Soto Machín L
    Rev Esp Anestesiol Reanim; 2011 Dec; 58(10):621-2. PubMed ID: 22263411
    [No Abstract]   [Full Text] [Related]  

  • 17. A novel approach to reversal of neuromuscular blockade.
    Della Rocca G; Pompei L
    Minerva Anestesiol; 2009 May; 75(5):349-51. PubMed ID: 19412157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sugammadex: an opportunity to change the practice of anesthesiology?
    Miller RD
    Anesth Analg; 2007 Mar; 104(3):477-8. PubMed ID: 17312188
    [No Abstract]   [Full Text] [Related]  

  • 19. Sugammadex.
    Golembiewski J
    J Perianesth Nurs; 2016 Aug; 31(4):354-7. PubMed ID: 27444769
    [No Abstract]   [Full Text] [Related]  

  • 20. Case report: sugammadex used to successfully reverse vecuronium-induced neuromuscular blockade in a 7-month-old infant.
    Buchanan CC; O'Donnell AM
    Paediatr Anaesth; 2011 Oct; 21(10):1077-8. PubMed ID: 21981096
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.